Market Research Logo

Firalis SAS - Product Pipeline Analysis, 2018 Update

Summary

Firalis SAS (Firalis) is a biotechnology company that develops biomarkers and biomarker-based diagnostic kits. The company’s biomarker products comprise recombinant proteins and calibrants, Elisa kits, and monoclonal antibodies, among others. It offers biomarker services such as flow cytometry, metabolomics and lipidomics, proteomics, genomics and transcriptomics, biobanking services, biomarker data analysis services, assay development and biomarker regulatory consultancy services, among others. Firalis also provides research and development on cardiovascular biomarkers, personalized medicine, drug safety and efficacy, patient stratification and new biomarker technologies and solutions, among others. It also discovers and develops biomarkers related to inflammatory disorders. Firalis is headquartered in Huningue, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Firalis SAS
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Firalis SAS Company Overview
Firalis SAS Company Snapshot 4
Firalis SAS Pipeline Products and Ongoing Clinical Trials Overview
Firalis SAS – Pipeline Analysis Overview 6
Firalis SAS - Key Facts 6
Firalis SAS - Major Products and Services 7
Firalis SAS Pipeline Products by Development Stage 8
Firalis SAS Pipeline Products Overview 10
Biomarker Test - Rheumatoid Arthritis 10
Biomarker Test - Rheumatoid Arthritis Product Overview 10
Companion Diagnostic Assay - Coxibs and NSAIDs 11
Companion Diagnostic Assay - Coxibs and NSAIDs Product Overview 11
Diagnostic Assay - Cardiovascular Diseases 12
Diagnostic Assay - Cardiovascular Diseases Product Overview 12
Diagnostic Kit - Acute Myocardial Infarction 13
Diagnostic Kit - Acute Myocardial Infarction Product Overview 13
Diagnostic Kit - Drug Induced Vasculitis 14
Diagnostic Kit - Drug Induced Vasculitis Product Overview 14
Diagnostic Kit - Non Drug Induced Vasculitis 15
Diagnostic Kit - Non Drug Induced Vasculitis Product Overview 15
Diagnostic Panel - Vasculitis 16
Diagnostic Panel - Vasculitis Product Overview 16
Micro-ELISA System 17
Micro-ELISA System Product Overview 17
Peripheral Biomarker - Minimal Vasculitis 18
Peripheral Biomarker - Minimal Vasculitis Product Overview 18
Prognostic miRNA Assay - Heart Failure 19
Prognostic miRNA Assay - Heart Failure Product Overview 19
Firalis SAS - Key Competitors 20
Firalis SAS - Key Employees 21
Firalis SAS - Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Firalis SAS, Recent Developments 23
Sep 19, 2014: Firalis Inaugurated its Biomarker Production Site 23
Feb 24, 2014: Firalis gets certified according to ISO 13485 and ISO 9001 standards; for the development and production of Firalis ELISA kits 23
Jan 09, 2014: Firalis Expands Service Offerings via New Bioanalytical Platform 23
Dec 24, 2013: Firalis launched a range of CE marked immunoassays for the titration of cardiovascular markers 24
Appendix 25
Methodology 25
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Firalis SAS Pipeline Products and Ongoing Clinical Trials Overview 4
Firalis SAS Pipeline Products by Equipment Type 5
Firalis SAS Pipeline Products by Indication 5
Firalis SAS, Key Facts 6
Firalis SAS, Major Products and Services 7
Firalis SAS Number of Pipeline Products by Development Stage 8
Firalis SAS Pipeline Products Summary by Development Stage 9
Biomarker Test - Rheumatoid Arthritis - Product Status 10
Biomarker Test - Rheumatoid Arthritis - Product Description 10
Companion Diagnostic Assay - Coxibs and NSAIDs - Product Status 11
Companion Diagnostic Assay - Coxibs and NSAIDs - Product Description 11
Diagnostic Assay - Cardiovascular Diseases - Product Status 12
Diagnostic Assay - Cardiovascular Diseases - Product Description 12
Diagnostic Kit - Acute Myocardial Infarction - Product Status 13
Diagnostic Kit - Acute Myocardial Infarction - Product Description 13
Diagnostic Kit - Drug Induced Vasculitis - Product Status 14
Diagnostic Kit - Drug Induced Vasculitis - Product Description 14
Diagnostic Kit - Non Drug Induced Vasculitis - Product Status 15
Diagnostic Kit - Non Drug Induced Vasculitis - Product Description 15
Diagnostic Panel - Vasculitis - Product Status 16
Diagnostic Panel - Vasculitis - Product Description 16
Micro-ELISA System - Product Status 17
Micro-ELISA System - Product Description 17
Peripheral Biomarker - Minimal Vasculitis - Product Status 18
Peripheral Biomarker - Minimal Vasculitis - Product Description 18
Prognostic miRNA Assay - Heart Failure - Product Status 19
Prognostic miRNA Assay - Heart Failure - Product Description 19
Firalis SAS, Key Employees 21
Firalis SAS, Other Locations 22
Glossary 27
List of Figures
Firalis SAS Pipeline Products by Equipment Type 5
Firalis SAS Pipeline Products by Development Stage 8

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report